Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

In-house & bespoke training:
Biopharma

Management Forum’s biopharma and biotech training courses will provide delegates with an overview of how biotech products are developed and manufactured as well as giving delegates an update on the scientific and regulatory environment, including biologic patent expiration and advances through biotech innovation.

 

Biosimilars

In-house & bespoke training

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

Rated by attendees to the public programme

Typically presented by Marloes van der Geer (bio)

Typical duration: 2 days
Pricing from £800 per attendee
Delivery: collaborative classroom

View details

Biotechnology for the Non-Biotechnologist

In-house & bespoke training

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Rated by attendees to the public programme

Typically presented by Adrian Haines (bio)
and 6 more leading experts

Typical duration: 3 days
Pricing from £1,200 per attendee
Delivery: collaborative classroom

View details

The content was excellent and all presenters were clearly SMEs, who managed to explain much of the complex content in an understandable way.

Sunil Singh, Director, Regulink Ltd

Excellent. Really enjoyed and learned a lot.

Anthony Barker, Director - Regulatory CMC, Home Address

I gained much more understanding than what I had intended to. The trainer also involved everybody in the course and did not make it boring. The topics of non-clinical, clinical, strategy as well as market entry/IP etc were covered briefly too. So that was an added advantage.

Anjali Apte, Manager, Regulatory Affairs, PharmaLex UK Services Ltd

Fully satisfied; even this was managed online, it was great.

, , Zentiva Group, a.s.

Really interesting, and a great introduction to someone with little/no knowledge of biotechnology. Also great that it went from scientific processes through to industrial processes. Nicely laid out. Well worth the three days!

Jackie Knipe, IP Paralegal, ALBUMEDIX LTD

I felt like the three days flowed together really well, first giving a basic understanding of the biology side of these products, how they are made and then their uses.

Laura Jones, Regulatory CMC Manager, AstraZeneca

The presentations were well prepared in general and I learned a lot.

Katja Pecjak, Director of Regulatory Affairs & QPPV, Billev farmacija vzhod d.o.o

Globally good presentation, speaker tried to make people participate which is difficult by webinar.

Frédéric LALLEMAND, Consultant, Lallemand Conseil

I thought it was a really interesting overview of biotechnology, from the specific scientific processes all the way through to the industry trends. I appreciated the discussion of advantages/ disadvantages and challenges of various methods and the industry as a whole, as I think this added a lot of context. This was beneficial for me when I was trying to apply what I had learned in the day to my specific company's context.

Sian Gilfillan, Marketing and Communications Associate, Albumedix

The course was comprehensive and the speakers were both subject matter experts and very good presenters. I really enjoyed the three days.

Linnea Elrington, VP, Head of HR, Silence Therapeutics